Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Neoplasm Metastasis 7 Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 7 Breast Neoplasms 4 Pancreatic Neoplasms 3 Lung Neoplasms 3 Urinary Bladder Neoplasms 2 Melanoma 2 Carcinoma, Renal Cell 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Cord Neoplasms 1 Spinal Cord Diseases 1 Spinal Cord Compression 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Prostate Cancer Metastatic Disease 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Mouth Neoplasms 1 Lymphatic Metastasis 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Epidural Neoplasms 1

Interventions

X-Rays 5 Phantoms, Imaging 5 Magnetic Resonance Spectroscopy 5 Nuclear Medicine Department, Hospital 4 Cyclophosphamide 4 fludarabine 3 Specimen Handling 3 Gemcitabine 3 Doxorubicin 3 Biopsy 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 olaparib 2 larotrectinib 2 ivosidenib 2 ensartinib 2 cabozantinib 2 Methotrexate 2 Mesna 2 Ifosfamide 2 Eflornithine 2 Cisplatin 2 tazemetostat 1 talazoparib 1 selinexor 1 pazopanib 1 palbociclib 1 mifamurtide 1 merphos 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Radiosurgery × 30 days × Clear all

NCT06492954 2026-06-02

AflacST2301

Emory University

Phase 1 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡